UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan‐Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall Survival

Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1)

(2019) Ken Konaka et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer

(2018) Yutaka Negoro et al.   International Journal of Clinical Oncology

Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key

(2017) N Singh et al.   INDIAN JOURNAL OF CANCER

Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy

(2017) Yu Bai et al.   OncoTargets and Therapy

Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key

(2017) N Singh et al.   INDIAN JOURNAL OF CANCER

Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer

(2016) Navneet Singh et al.   Clinical Lung Cancer

The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer

(2015) Xiaoguang Xiao et al.   OncoTargets and Therapy

Tumor cavitation among lung cancer patients receiving first-line chemotherapy at a tertiary care centre in India: association with histology and overall survival

(2013) Navneet Singh et al.   MEDICAL ONCOLOGY

Management of advanced lung cancer in resource-constrained settings: a perspective from India

(2012) Navneet Singh et al.   Expert Review of Anticancer Therapy

Unchanging clinico-epidemiological profile of lung cancer in North India over three decades

(2010) Navneet Singh et al.   Cancer Epidemiology

Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review

(2009) Glenn E Palomaki et al.   GENETICS IN MEDICINE

Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes

(2008) J. M. Hoskins et al.   CLINICAL CANCER RESEARCH

Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan

(2008) N Yamamoto et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer

(2008) Ji-Youn Han et al.   LUNG CANCER